Bulvas Miroslav
Charles University Prague, Third School of Medicine, University Hospital Královské Vinohrady, Department of Surgery and Division of Interventional Angiology, Prague, Czech Republic.
Surg Technol Int. 2020 May 28;36:225-232.
Mechanical atherothrombectomy (MATH) with the Rotarex® S (Straub Medical AG, Wangs, Switzerland) catheter is an endovascular therapeutic technique for removing fragmentable occlusive material from the lumen of peripheral vessels. It can be used as a rapid, safe and efficacious initial modality for the treatment of acute or subacute ischemia of the lower limbs, even in patients with an immediately threatened extremity and those with a contraindication for surgical and/or thrombolytic therapy. Patient placement in an intensive care unit and routine embolic prevention with a filter are not necessary. In the literature, the technical success of MATH has varied from 92% to 100%, with lower rates in subgroups with occluded bypass grafts (78%) and a crossover approach (56%). The number of secondary surgical revascularization procedures has ranged from 0% to 5.3% and the mortality rate at 30 days has varied between 0% and 1%. The 30-day clinical success has varied from 68% to 98%, secondary patency from 68% to 97.6%, amputation-free survival from 94.4% to 100%, frequency of major complications from 0% to 6.9%, major hemorrhage from 0% to 2.6% and frequency of major debulking device-related complications from 0% to 0.4%.
使用Rotarex® S(瑞士王斯市施特劳布医疗股份公司)导管进行机械性动脉粥样硬化血栓切除术(MATH)是一种血管内治疗技术,用于从外周血管腔中清除可破碎的闭塞物质。它可作为治疗下肢急性或亚急性缺血的快速、安全且有效的初始治疗方式,即使是对于肢体立即受到威胁的患者以及存在手术和/或溶栓治疗禁忌证的患者。无需将患者安置在重症监护病房,也无需常规使用过滤器进行栓塞预防。在文献中,MATH的技术成功率在92%至100%之间,在闭塞旁路移植物亚组(78%)和交叉入路亚组(56%)中成功率较低。二次手术血运重建手术的比例在0%至5.3%之间,30天死亡率在0%至1%之间。30天临床成功率在68%至98%之间,二次通畅率在68%至97.6%之间,无截肢生存率在94.4%至100%之间,主要并发症发生率在0%至6.9%之间,大出血发生率在0%至2.6%之间,主要减容装置相关并发症发生率在0%至0.4%之间。